# Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer

> **NCT06467786** · PHASE4 · RECRUITING · sponsor: **Tang-Du Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** Irinotecan hydrochloride liposome injection

## Key facts

- **NCT ID:** NCT06467786
- **Lead sponsor:** Tang-Du Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-15
- **Primary completion:** 2025-09-15
- **Final completion:** 2028-09-15
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06467786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06467786, "Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06467786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*